Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population

Study summary

The aim of this study is to describe the outcomes in American Indian patients receiving immunotherapy in a multi-institution retrospective study at several other high-volume centers that care for this patient population and to identify any healthcare disparities that can lead to future interventional studies.

Ask AI to explain this study

Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedImmunotherapy

The study team can explain what participation involves.

Who it may be forMetastatic or stage IV

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Sep 18, 2026 · Source: ClinicalTrials.gov

Is enrollment open?Active Not Recruiting

The study is underway but is not accepting new participants.

What kind of study?Not applicable

Observational

Where is it offered?6 U.S. locations

Locations may change over time.

Who runs it?University of Oklahoma

Study sponsor

Study overview

What this study is about

Purpose: Not specified
Study type: Observational
Phase: Not applicable
Sponsor: University of Oklahoma
Interventions being studied: Biological: Immunotherapy

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Disease setting

Metastatic or stage IV→

Treatment approach

Immunotherapy→

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

above age 18,
histologically and cytologically confirmed NSCLC, melanoma, head and neck squamous cell carcinoma, gastrointestinal cancers,, renal cell carcinoma, or any other solid tumors where immune checkpoint therapy has been used
received immunotherapy as part of their treatment
Self-identified American Indian in ethnicity
Patients at the Stephenson Cancer Center between 2015 to 2021

Reasons someone may not be able to joinExclusion criteria

patients who did not receive immune checkpoint inhibitor therapy

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

Arizona Cancer Center at the Unvieristy of ArizonaTucson, Arizona
University of New Mexico Comprehensive Cancer CenterAlbuquerque, New Mexico
Stephenson Cancer CenterOklahoma City, Oklahoma
Monument Health Cancer Care InstituteRapid City, South Dakota
Avera Cancer InstituteSioux Falls, South Dakota
Huntsman Cancer Institute at the University of UtahSalt Lake City, Utah

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Sep 18, 2026. Always confirm current availability with the study team.

View original record ↗